Marko Lucijanic (Ivan Papic, Marko Lucijanić)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 94

Top Topics

Pulmonary Embolism

Coronavirus Disease

Oral Anticoagulants

Top Venues

Leukemia & lymphoma

Annals of hematology

Wiener klinische Wochenschrift

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ivan Papic, Petra Bistrovic, Tomislav Cikara, Nikolina Busic, Tatjana Kereš, Maja Ortner Hadžiabdić, Marko Lucijanic
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. Viruses 16 (1) (2024)
Marko Lucijanic, Ivan Krecak, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Danijela Lekovic, Rajko Kusec
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis. Annals of hematology 103 (6) (2024)
Marko Lucijanic, Ivan Krecak, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Danijela Lekovic, Rajko Kusec
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis. Annals of hematology (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Andrija Bogdanović, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications. Journal of clinical medicine 13 (15) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Ivan Krecak, Sanja Klobucar Majanovic, Josipa Budimir, Marko Skelin, Marko Lucijanic
Diabetes mellitus, metformin, and the risk of MPN. Blood advances (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Tamara Vasilj, David Cicic, Anamarija Vrkljan Vuk, Zvonimir Kremer, Ivo Dilber, Anton Glasnovic, Ozren Jaksic, Rajko Kusec
Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk. Scandinavian journal of clinical and laboratory investigation 84 (2) (2024)
Ivan Papic, Petra Bistrovic, Tomislav Cikara, Nikolina Busic, Tatjana Kereš, Maja Ortner Hadžiabdić, Marko Lucijanic
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. Viruses 16 (1) (2024)
Ivan Papic, Petra Bistrovic, Tomislav Cikara, Nikolina Busic, Tatjana Kereš, Maja Ortner Hadžiabdić, Marko Lucijanic
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. Viruses 16 (1) (2024)
Marko Lucijanic, Robert Likic, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. Life (Basel, Switzerland) 14 (4) (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift (2024)
Marko Lucijanic, Robert Likic, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. Life (Basel, Switzerland) 14 (4) (2024)
Marko Lucijanic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use. Journal of psychopharmacology (Oxford, England) 38 (4) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Marko Lucijanic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use. Journal of psychopharmacology (Oxford, England) 38 (4) (2024)
Robert Likic, Danijela Lekovic, Andrija Bogdanovic, Marko Lucijanic
High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera. Leukemia & lymphoma (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma 65 (5) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma 65 (5) (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Andrija Bogdanović, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications. Journal of clinical medicine 13 (15) (2024)
Ivan Papic, Petra Bistrovic, Tomislav Cikara, Nikolina Busic, Tatjana Kereš, Maja Ortner Hadžiabdić, Marko Lucijanic
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. Viruses 16 (1) (2024)
Tanja Staraj Bajcic, Iva Sorta-Bilajac Turina, Marko Lucijanic, Tamara Sinozic, Mirela Vuckovic, Ksenija Bazdaric
Cyberchondria, Health Literacy, and Perception of Risk in Croatian Patients with Risk of Sexually Transmitted Infections and HIV-A Cross-Sectional Study. Epidemiologia (Basel, Switzerland) 5 (3) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology (2024)
Ivan Papic, Petra Bistrovic, Tomislav Cikara, Nikolina Busic, Tatjana Kereš, Maja Ortner Hadžiabdić, Marko Lucijanic
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. Viruses 16 (1) (2024)
Marko Lucijanic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use. Journal of psychopharmacology (Oxford, England) 38 (4) (2024)
Marko Lucijanic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use. Journal of psychopharmacology (Oxford, England) (2024)
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Tamara Vasilj, David Cicic, Anamarija Vrkljan Vuk, Zvonimir Kremer, Ivo Dilber, Anton Glasnovic, Ozren Jaksic, Rajko Kusec
Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk. Scandinavian journal of clinical and laboratory investigation (2024)
Karlo Petkovic, Zdeslav Strika, Robert Likić, Marko Lucijanic
Spotlight commentary: Integrating artificial intelligence in clinical pharmacology: Opportunities, challenges and ethical imperatives. British journal of clinical pharmacology (2024)
Marko Lucijanic, Nikolina Busic, Josip Stojic, Mislav Barisic-Jaman, Nikola Zagorec, Karla Lazibat, Antica Pasaric, Anamarija Vrkljan Vuk, Ivan Durlen, Josko Mitrovic, Ivica Luksic, Bruno Barsic
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate. Expert opinion on drug safety (2023)
Hrvoje Holik, Ivan Krečak, Marko Lucijanic, Ivan Samardžić, Danijel Pilipac, Ivana Vučinić Ljubičić, Božena Coha, Alma Kitter Pipić, Blaženka Miškić, Silva Zupančić-Šalek
Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study. Life (Basel, Switzerland) 13 (6) (2023)
Marko Lucijanic, Petra Veic, Ivona Aric, Katarina Marija Tupek, Ena Soric, Anica Sabljic, Josipa Vlasac Glasnovic, Tajana Stoos-Veic, Ivan Krecak, Rajko Kusec
Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time. Annals of hematology (2023)
Dijana Lucijanic, Alma Mihaljevic Peles, Nevenka Piskač Živković, Marko Lucijanic, Matija Kranjcevic, Lana Muzinic Marinic
Relationship of Anxiety, Depression, Stress, and Post-Traumatic Stress Disorder Symptoms with Disease Severity in Acutely Ill Hospitalized COVID-19 Patients. Behavioral sciences (Basel, Switzerland) 13 (9) (2023)
Marko Lucijanic, Ivan Krecak, Iva Busic, Armin Atic, Josip Stojic, Anica Sabljic, Ena Soric, Petra Veic, Sanja Marevic, Lovorka Derek, Josko Mitrovic, Ivica Luksic
Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes. Journal of thrombosis and thrombolysis (2023)
Marko Lucijanic, Anica Sabljic, Josipa Vlasac Glasnovic, Ena Soric, Zeljko Jonjic, Rajko Kusec
Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab. Annals of hematology (2023)
Marko Lucijanic, Daniela Marelic, Josip Stojic, Ivan Markovic, Filip Sedlic, Ivan Kralj, Davor Rucevic, Niksa Busic, Patrik Javor, Tomo Lucijanic, Josko Mitrovic, Ivica Luksic
Predictors of prolonged hospitalization of COVID-19 patients. European geriatric medicine (2023)
Robert Likic, Ivan Zekanović, Martina Morić Perić, Hrvoje Holik, Božena Coha, Vlatka Periša, Marko Lucijanic
High plateletcrit may be associated with thrombotic risk in polycythemia vera. International journal of laboratory hematology (2023)
Marko Lucijanic, Robert Likic
The Complete Blood Count: Increasing Its Precision and Impact. Annals of internal medicine 176 (8) (2023)
Marko Lucijanic, Ivan Krecak
Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of thrombosis and thrombolysis (2023)
Marko Lucijanic, Daniela Marelic, Josip Stojic, Ivan Markovic, Filip Sedlic, Ivan Kralj, Davor Rucevic, Niksa Busic, Patrik Javor, Tomo Lucijanic, Josko Mitrovic, Ivica Luksic
Predictors of prolonged hospitalization of COVID-19 patients. European geriatric medicine (2023)
Marko Lucijanic, Cedna Tomasovic-Loncaric, Tajana Stoos-Veic, Tomislav De Both, Barbara Jalsenjak, Rajko Kusec
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine. Annals of hematology (2023)
Robert Likic, Marko Lucijanic
Duffy-null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia. EJHaem 4 (4) (2023)
Ivan Krečak, Ljerka Pivac, Marko Lucijanic, Marko Skelin
Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines 11 (5) (2023)
Marko Lucijanic, Robert Likic, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Palpable spleen size is differently prognostic in primary and secondary myelofibrosis. Leukemia & lymphoma (2023)
Hrvoje Holik, Ivan Krečak, Marko Lucijanic, Ivan Samardžić, Danijel Pilipac, Ivana Vučinić Ljubičić, Božena Coha, Alma Kitter Pipić, Blaženka Miškić, Silva Zupančić-Šalek
Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study. Life (Basel, Switzerland) 13 (6) (2023)
Marko Lucijanic, Ida Tjesic-Drinkovic, Nevenka Piskač Živković, Frane Paštrovic, Zrinka Rob, Mersiha Bacevac, Martina Sedinic Lacko, Eleonora Dzambas, Barbara Medic, Ivan Vukoja, Iva Busic, Ivica Grgurević, Ivica Luksic, Bruno Barsic
Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients. Life (Basel, Switzerland) 13 (8) (2023)
Robert Likic, Monika Čeko, Karla Nižetić, Eva Čubrić, Mediana Županović, Marko Skelin, Marko Lucijanic
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism. Scandinavian journal of clinical and laboratory investigation (2023)
Nikolina Busic, Tomo Lucijanic, Bruno Barsic, Ivica Luksic, Iva Busic, Goran Kurdija, Ljubo Barbic, Sanja Kunstek, Tea Jelic, Marko Lucijanic
Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: Differences between vector and mRNA vaccines. Journal of medical virology 94 (6) (2022)
Marko Lucijanic, Ivan Krecak, Rajko Kusec
Renal disease associated with chronic myeloproliferative neoplasms. Expert review of hematology 15 (2) (2022)
Zrinka Sertić, Marko Lucijanic, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, Dražen Pulanić, Zinaida Perić, Lana Desnica, Mirta Mikulić, Marijo Vodanović, Ivo Radman-Livaja, Dragana Šegulja, Dunja Rogić, Toni Valković, Igor Aurer, Nadira Duraković
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines 10 (11) (2022)
Marko Lucijanic, Josip Stojić, Armin Atić, Tomislav Čikara, Besa Osmani, Mislav Barišić-Jaman, Ana Andrilović, Petra Bistrović, Anamarija Zrilić Vrkljan, Marko Lagančić, Marko Milošević, Ivan Vukoja, Lovorka Đerek, Tomo Lucijanić, Nevenka Piskač Živković
Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients : Data on 2309 patients from a tertiary center and validation in an independent cohort. Wiener klinische Wochenschrift 134 (9-10) (2022)
Marko Lucijanic, Martina Demaria, Jelena Gnjidic, Zrinka Rob, Dora Filipovic, Toni Penovic, Ana Jordan, Mislav Barisic-Jaman, Frane Pastrović, Dijana Lucijanic, Tomislav Cikara, Tomo Lucijanic, Marko Miletic, Divo Ljubicic, Tatjana Keres
Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis. Annals of hematology 101 (5) (2022)
Ivica Grgurević, Marko Lucijanic, Frane Paštrovic, Mislav Barisic Jaman, Ida Tjesic Drinkovic, Marko Zelenika, Marko Milosevic, Barbara Medic, Dusko Kardum, Tomislav Bokun, Ivica Luksic, Nevenka Piskac Zivkovic, Tatjana Keres, Vlatko Grabovac, Jasminka Persec, Bruno Barsic
Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19. Internal medicine journal 52 (11) (2022)
Marko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, Stjepan Kovacevic, Armin Atic, Vlatko Pejsa, Rajko Kusec
Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes. Leukemia & lymphoma 63 (7) (2022)
Marko Lucijanic, Ena Soric, Martina Sedinic Lacko, Anica Sabljic, Ivan Krecak, Petra Bistrovic, Ana Jordan, Sime Manola, Ozren Jaksic, Tomo Lucijanic, Lovorka Derek, Rajko Kusec
Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients. Journal of medical virology 94 (8) (2022)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine Alma Knudsen, Marko Lucijanic, Rajko Kusec
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 14 (22) (2022)
Marko Lucijanic, Ivan Krecak, Davor Galusic, Martina Sedinic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Vlatko Pejsa, Rajko Kusec
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis. Wiener klinische Wochenschrift (2021)
Josip Stojic, Vlatko Grabovac, Marko Lucijanic
Needlestick and sharp injuries among healthcare workers prior to and during the coronavirus disease 2019 (COVID-19) pandemic. Infection control and hospital epidemiology (2021)
Marko Lucijanic, Renata Huzjan Korunić, Martina Sedinić, Rajko Kušec, Vlatko Pejša
Prognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type. Leukemia & lymphoma 62 (10) (2021)
Irzal Hadžibegović, Ivana Jurin, Tomislav Letilović, Vedran Radonić, Hrvoje Jurin, Štefica Mikšić, Marko Lucijanic
Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers. Expert review of cardiovascular therapy 19 (9) (2021)
Marko Zelenika, Marko Lucijanic, Tomislav Bokun, Tonci Bozin, Mislav Barišić Jaman, Ida Tjesic Drinkovic, Frane Paštrovic, Anita Madir, Ivica Luksic, Nevenka Piskac Zivkovic, Kresimir Luetic, Zeljko Krznaric, Rajko Ostojic, Tajana Filipec Kanizaj, Ivan Bogadi, Lucija Virovic Jukic, Michal Kukla, Ivica Grgurević
FibroScan-AST Score Predicts 30-Day Mortality or Need for Mechanical Ventilation among Patients Hospitalized with COVID-19. Journal of clinical medicine 10 (19) (2021)
Petra Bistrovic, Marko Lucijanic
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study. Journal of medical virology 93 (10) (2021)
Marko Lucijanic, Renata Huzjan Korunic, Marija Ivic, Amina Fazlic Dzankic, Rajko Kusec, Vlatko Pejsa
Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients. Hematological oncology 39 (4) (2021)
Marko Lucijanic, Nevenka Piskac Zivkovic, Marija Ivic, Martina Sedinic, Boris Brkljacic, Andrea Mutvar, Armin Atic, Diana Rudan, Bruno Barsic, Ivica Luksic, Rajko Kusec, Gordana Ivanac
Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients. Wiener klinische Wochenschrift (2021)
Marko Lucijanic, Ivan Krecak, Srdan Verstovsek, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis. Annals of hematology (2021)
Marko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, Rajko Kusec, Vlatko Pejsa
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features. Therapeutics and clinical risk management 17 (2021)
Petra Bistrovic, Sime Manola, Marko Lucijanic
Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre. Postgraduate medical journal (2021)
Marko Lucijanic, Ivan Krecak, Ena Soric, Martina Sedinic, Anica Sabljic, Lovorka Derek, Ozren Jaksic, Rajko Kusec
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood cancer journal 11 (11) (2021)
Marko Lucijanic, Rajko Kusec
Ruxolitinib withdrawal due to the COVID-19. Leukemia 35 (4) (2021)
Ivana Jurin, Marko Lucijanic, Vedran Radonić, Tomislav Letilović, Josip Pejić, Jelena Lucijanić, Ida Tješić-Drinković, Sanda Sokol Tomić, Irzal Hadžibegović
Patients with dementia and atrial fibrillation less frequently receive direct oral anticoagulants (DOACs) and experience higher thrombotic and mortality risk. Acta clinica Belgica (2021)
Frane Paštrovic, Marko Lucijanic, Armin Atic, Josip Stojic, Mislav Barišić Jaman, Ida Tjesic Drinkovic, Marko Zelenika, Marko Milosevic, Barbara Medic, Jelena Loncar, Maja Mijic, Tajana Filipec Kanizaj, Dominik Kralj, Ivan Lerotic, Lucija Virovic Jukic, Neven Ljubicic, Kresimir Luetic, Dora Grgic, Matea Majerovic, Rajko Ostojic, Zeljko Krznaric, Ivica Luksic, Nevenka Piskac Zivkovic, Tatjana Kereš, Vlatko Grabovac, Jasminka Peršec, Bruno Barsic, Ivica Grgurević
Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients. Journal of clinical medicine 10 (18) (2021)
Ivana Jurin, Marko Lucijanic, Vedran Radonić, Tomislav Letilović, Jelena Lucijanić, Stjepan Mesarov, Nikola Zagorec, Irzal Hadžibegović
The Risk of Falling and Consequences of Falling in Patients with Atrial Fibrillation Receiving Different Types of Anticoagulant. Drugs & aging 38 (5) (2021)
Antonio Bulum, Gordana Ivanac, Eugen Divjak, Iva Biondić Špoljar, Martina Džoić Dominković, Kristina Bojanic, Marko Lucijanic, Boris Brkljacic
Elastic Modulus and Elasticity Ratio of Malignant Breast Lesions with Shear Wave Ultrasound Elastography: Variations with Different Region of Interest and Lesion Size. Diagnostics (Basel, Switzerland) 11 (6) (2021)
Marko Lucijanic, Davor Galusic, Robert Likic, Martina Sedinic, Ena Soric, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Rajko Kusec
C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Leukemia & lymphoma 61 (12) (2020)
Robert Likic, Marko Lucijanic, Velka Gverić-Krečak, Nadira Duraković
Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera. Leukemia & lymphoma 61 (7) (2020)
Marko Lucijanic, Davor Galusic, Ena Soric, Martina Sedinic, Marta Cubela, Renata Huzjan Korunic, Vlatko Pejsa, Rajko Kusec
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of hematology 100 (4) (2020)
Marko Lucijanic, Miran Lovrinov, Marko Skelin
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes. Annals of internal medicine 173 (7) (2020)
Marko Lucijanic, Davor Galusic, Ivan Krecak, Martina Sedinic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Rajko Kusec
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis. Annals of hematology 99 (12) (2020)
Vlatko Pejsa, Marko Lucijanic, Anamarija Vrkljan Vuk, Tajana Stoos-Veic, Ozren Jaksic, Zeljko Jonjic, Mario Pirsic, Zeljko Prka, Marija Ivic, Amina Fazlic Dzankic, Zdravko Mitrovic
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia. Leukemia & lymphoma 61 (4) (2019)
Marko Lucijanic, Rajko Kusec
Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? British journal of haematology 186 (4) (2019)
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, Tajana Stoos-Veic, Vlatko Pejsa, Zeljko Jonjic, Amina Fazlic Dzankic, Marija Ivic, Rajko Kusec
Neutral effect of Glioma-associated oncogene-1 expression on survival in myelofibrosis. Wiener klinische Wochenschrift 132 (15-16) (2019)
Marko Lucijanic, Marko Skelin, Rajko Kusec
Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. Leukemia 33 (10) (2019)
Marko Lucijanic, Ivo Veletic, Dario Rahelic, Vlatko Pejsa, David Cicic, Marko Skelin, Ana Livun, Katarina Marija Tupek, Tajana Stoos-Veic, Tomo Lucijanic, Ana Maglicic, Rajko Kusec
Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis. Wiener klinische Wochenschrift 130 (3-4) (2018)
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, Tajana Stoos-Veic, Vlatko Pejsa, Rajko Kusec
Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis. Annals of hematology 97 (7) (2018)
Marko Lucijanic, Zeljko Prka, Ozren Jaksic, Zdravko Mitrovic, Anamarija Vrkljan, Vlatko Pejsa
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality. American journal of hematology 94 (2) (2018)
Marko Lucijanic, Ana Livun, Tajana Stoos-Veic, Vlatko Pejsa, Ozren Jaksic, David Cicic, Jelena Lucijanić, Zeljko Romic, Biserka Orehovec, Gorana Aralica, Marko Miletic, Rajko Kusec
High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis. Hematology (Amsterdam, Netherlands) 23 (4) (2017)
Marko Lucijanic, Sead Ziga, Ivica Grgurevic
Comment to: "Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs". Journal of gastroenterology 52 (9) (2017)
Marko Lucijanic, Zdravko Mitrovic, David Cicic, Zeljko Prka, Vlatko Pejsa, Ana Livun, Tajana Stoos-Veic, Zeljko Romic, Marcela Zivkovic, Iva Lucijanic, Zrinka Fabris, Rajko Kusec
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis. International journal of hematology 107 (2) (2017)